A Randomized, Double-Blind, Three-Period Crossover Study to Evaluate the Effect of Different Warm-Up Times of Risankizumab Autoinjector (AI) on the Injection Pain Experiences in Healthy Volunteers
Latest Information Update: 14 Mar 2022
At a glance
- Drugs Risankizumab (Primary)
- Indications Atopic dermatitis; Crohn's disease; Erythrodermic psoriasis; Generalised pustular psoriasis; Hidradenitis suppurativa; Palmoplantar pustulosis; Plaque psoriasis; Psoriasis; Psoriatic arthritis; Ulcerative colitis
- Focus Adverse reactions; Therapeutic Use
- Sponsors AbbVie
- 14 Mar 2022 New trial record